Showing results (21-30 of 52) with videos related to
Sort By:
Pageof 6
The American Journal of Pathology|February 5, 2014
Increased severity of tuberculosis in Guinea pigs with type 2 diabetes: a model of diabetes-tuberculosis comorbidityBrendan K Podell, David F Ackart, Andres Obregon-Henao, et al.Viruses|June 21, 2020
Cyclin-Dependent Kinases 8 and 19 Regulate Host Cell Metabolism during Dengue Virus Serotype 2 InfectionMolly Butler, Nunya Chotiwan, Connie D Brewster, et al.Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Preparation Strategies of the Anti-Mycobacterial Drug Bedaquiline for Intrapulmonary Routes of AdministrationSara E Maloney, Ian E Stewart, Brendan K Podell, et al.Antimicrobial Agents and Chemotherapy|November 15, 2023
A preclinical model of TB meningitis to determine drug penetration and activity at the sites of diseaseFaye Lanni, Rosleine Antilus Sainte, Mark Hansen, et al.Frontiers in Microbiology|September 12, 2022
Therapeutic efficacy against Mycobacterium tuberculosis using ID93 and liposomal adjuvant formulationsSusan L Baldwin, Valerie A Reese, Sasha E Larsen, et al.Pathogens and Disease|January 31, 2014
Expression of antimicrobial drug tolerance by attached communities of Mycobacterium tuberculosisDavid F Ackart, Laurel Hascall-Dove, Silvia M Caceres, et al.Biorxiv : the Preprint Server for Biology|June 9, 2023
Establishment of CD1b-restricted immunity to lipid antigens in the pulmonary response to Mycobacterium tuberculosis infectionMacallister C Harris, Hadley E Gary, Sarah K Cooper, et al.Biorxiv : the Preprint Server for Biology|April 3, 2026
Adaptive immunity shapes baseline physiology of M. tuberculosis in high-dose versus low-dose infection BALB/c mouse drug treatment modelsJo Hendrix, Reem Al Mubarak, Karen Rossmassler, et al.Scientific Reports|April 28, 2021
Subunit vaccine protects against a clinical isolate of Mycobacterium avium in wild type and immunocompromised mouse modelsSasha E Larsen, Valerie A Reese, Tiffany Pecor, et al.Antimicrobial Agents and Chemotherapy|July 31, 2026
Adaptive immunity shapes baseline physiology of M. tuberculosis in high-dose versus low-dose infection BALB/c mouse drug treatment modelsJo Hendrix, Reem Al Mubarak, Karen Rossmassler, et al.Pageof 6